A Breakthrough in COVID-19 Testing
Introducing the MicroGEM Sal6830 Point-of-Care RT-qPCR Test System, the only Health Canada and FDA authorized* PCR-based Saliva Test for COVID-19 detection at the point-of-care.
Sal6830 combines easy-to-collect saliva samples with an extraction free process for ultrafast PCR results. Make quick decisions about a person’s health at the point-of-care.
Non-invasive
Easy-to-collect saliva
sample is non-invasive,
making testing more
comfortable than nasal
swabs
Results in under 30 minutes
Returns results in 27
minutes.
Anytime, anywhere
PCR testing where and when it is needed for real-time decision
making.
High-performance PCR
FDA authorized* point-of-care technology captures
intact virus, an important
indicator of infection.
Saliva-based PCR tests are ideal for congregate work settings
- Companies requiring employees to come back into the physical office.
- Remote mining operations where PCR testing is not readily available.
- Manufacturing facilities where physical distancing is not possible and avoiding downtime is critical.
- Sports tournaments where players come in close contact over the course of a few days.
Authorized for emergency use Health Canada
Authorized for emergency use by the FDA under an EUA for use by authorized laboratories or under a CIA waiver.
Developed with the support from the National Institutes of Health (NIH), Rapid Acceleration of Diagnostics (RADx) initiative.
Why Sal6830?
- Detects a current SARS-CoV-2 infection: Traditional PCR tests may detect fragments of the virus from a previous COVID-19 infection. Sal6830 was designed to capture the intact virus, a key indicator of a current and transmissible infection.
- Robust with existing variants: Clinically evaluated during both the Delta and Omicron waves, the multiple SARS-CoV-2 gene targets allow for robust detection of current variants and protect against obsolescence from future variants.
- Portable: The platform’s small size is easily incorporated at testing sites such as mobile testing labs, ambulatory surgical centers, emergency departments, workplaces, and gathering places.
Why Saliva?
Painless sampling Eliminates the need for uncomfortable swab testing.
Self-collected samples Limits worker exposure, decreasing the risk of viral transmission..
Resistant to global supply chain shortages Does not require any additional materials to carry out a test. Proudly developed and manufactured in the United States.
Rapid and accurate COVID-19 RT-qPCR test result in three simple steps
1. Obtain saliva sample
2. Connect cup to cartridge
3. Insert and run test
“We see many patients who are anxious about nasal swabs so we are excited about the opportunity to offer saliva testing. If patients are comfortable providing the sample and quickly get their results, then they are more likely to be receptive to ongoing care and future testing.”
Songbird Life Science is the exclusive distributor of Sal6830 for industrial settings in Canada and the United States
Songbird Solutions Consultants can help determine the ideal point-of-care testing solution for a specific situation, environment, and/or population.